BUSINESS COMPLIANCE
BUSINESS COMPLIANCE, VOLUME 2, NO. 2, APRIL 2013
Welcome to this 2nd issue of the Journal of Business compliance, as business returns to normal after the Easter break. The spirit of Spring is upon us and we might all look to the future with hope and optimism. This very human ability has been essential to our survival as a species; and possibly remains so to the careers and aspirations of ethics and governance workers?
During the short interval between our February issue and the time of writing, there have been plenty of events to concern us with. Failures of governance and leadership have beset celebrated, public institutions like the British National Health System where the governing board of Stafford Hospital appeared to have lost all sight of their reason for being. Elsewhere, careers and egos have been broken or bruised at the top of industry. At Swedish TeliaSonera, the simple lack of care and due diligence checks on third party associates led to suspicions of corruption and the resignation of their CEO.
As the storm continues to rage around the link between corporate responsibility, greed and executive pay, EU and Swiss legislators have adjudged the compensation packages offered to captains of industry, for good or bad performance, to be such that greater shareholder scrutiny is required.
To read the complete editorial CLICK HERE
LIFE SCIENCE COMPLIANCE
Content update: Volume 2, No. 1, March 2013
Our first article in this issue comes from Elisabethann Wright and Alexander Roussanov of Hogan Lovells and highlights the implications of EU data privacy rules for global product helplines.
James Paterson, founder of Risk & Assurance Insights Ltd, and a former Head of Internal Audit at AstraZeneca, takes us through how to run an effective internal audit department with special focus on the relationships and interactions between Internal Audit and Compliance.
We move to the USA for our next article by Karen A. Popp and David J. Ludlow who are both partners in Sidley Austin LLP’s White Collar, Government Investigations, and FCPA practices team. The US Department of Justice and Securities Exchange Commission recently issued guidance on the Foreign Corrupt Practices Act (FCPA). Whilst the FCPA is a piece of US legislation, it has global impact (the clue is in the word “foreign”) and there will be few organisations operating within the Life Science industry that will not need to take note of this guidance.
Next, we have an Opinion article from Nick Broughton of Pharmaceuticalethics.com, who asks “Can Pharma Be Loved?”. This article is the first in a series of articles intended to challenge our thinking about our industry.
Each issue from now on will feature a Case Study that will set out a situation for discussion online among our readers and contributors. Edited highlights from the online discussion will be published in the following issue together with the next Case Study for discussion. This should help to bring your challenges to life by gathering many different views on a hot topic. Do join us for the online discussion; the LinkedIn group name is “Life Science Compliance Discussions”.
We complete this issue with a review of the 13th Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum held in Washington from 5th to 7th November 2012.
To read the complete editorial CLICK HERE
BUSINESS COMPLIANCE
1st issue of 2013 - OUT NOW!
Another year is underway, and we have closed the door on 2012 with its numerous examples of compliance and governance failures involving allegations of bribery by Walmart in Mexico, failure to prevent moneylaundering at HSBC, manipulation of Libor rate submissions by Barclays Bank and others, rogue trading and/or major operational failures elsewhere in finance, and misselling of medicines at GlaxoSmithKline, to mention but a few. We have hardly embarked upon the new year and we already have examples of the continued enforcement activity of regulators, including the closure of a bank and the imposition of fines in the order of USD 1.5 billion. The failure of the high profile UK firm, HMV – famous for its high street offerings of CDs and DVDs – follow on from earlier examples of governance structures and board direction proving unable to steer their companies to long term success in the digital age. The need for the continued debate and knowledgeshare which underpins the purpose of this Journal appears assured therefore. We have had a very favourable response to our inaugural issue of the Journal. We would like to thank all of our readers, contributors and reviewers who have provided very encouraging feedback to the editorial and publisher teams. We are also very pleased to welcome Dr Mark Pieth to the Editorial Board. His experience as Professor of Criminal Law and Criminology at the University of Basel, Switzerland, and as Chairman of the Board of the Basel Institute on Governance, will most certainly enhance the work of the Board and, we believe, enrich the content of the Journal immensely.
To read the complete editorial CLICK HERE
INTERNATIONAL JOURNAL OF WATER GOVERNANCE
LAUNCH OF THE JOURNAL
We are proud to present you the very first issue of the International Journal on Water Governance (IJWG). The aim of this journal is to become an important source of knowledge on governance of complex water systems, and a source of inspiration for all professionals in the water domain to improve the governance capacity. We want to focus on actual and urgent theoretical issues and bring them further by application and elaboration in the domains of water. From a variety of disciplines, we will gather new insights on what constitutes the governance capacity with regard to specific topics, like water quality, flooding and scarcity.
Governance is the crucial overarching concept in our journal. The Oxford Handbook of Governance opens with the following characterization: “Governance is said to be many things, including a buzzword, a fad, a framing device, a bridging concept, an umbrella concept, a descriptive concept, a slippery concept, an empty signifier, a weasel word, a fetish, a field, an approach, a theory and a perspective” (Levi-Faur, 2012: 3). Indeed, there are many definitions of governance and the concept is used for nearly everything related to issues of organizing collective action. Nevertheless, it indicates one of the most important side-effects of modernizations: increased interdependency and the need for joint action. That is also what is needed in the domain of water and therefore it is crucial to speed up in understanding the essentials of water governance....
BUSINESS COMPLIANCE
Welcome to the launch issue of the Journal of Business Compliance. It was 12 months ago that a group of Compliance Officers came together and concluded that there was a gap; something missing in the compliance information sphere. There was a need for a concentrated source of knowledge leading to a better exchange of best practice, practical learnings, and tools, to help promote ethics and integrity in Business, and to assist Compliance Officers in the quest for an effective compliance organisation. In this, and future issues, the Editorial Board has put together a series of articles that we believe, and hope, are in line with this objective. We are dedicated to providing a platform for thought leaders to combine intellectual understanding with practical outcome. We aim to deliver articles that inform, educate, share best practice and knowledge and leave the reader inspired to apply the learning’s received, or otherwise practically benefit from the different perspectives delivered...
LIFE SCIENCE COMPLIANCE
Welcome to the fourth issue of Life Science Compliance. As a brief reminder, the aim of the Journal is to provide information for those working in compliance and related fields in life science companies, law firms and consultancies.
From this issue onwards, we welcome both Reinhard Angelmar and Chris Zalesky as new members of our Editorial Board. Reinhard is Emeritus Professor of Marketing and the Salmon and Rameau Fellow of Healthcare Management, Emeritus, INSEAD, Fontainebleau, France. Chris is VP, Global Policy & Guidance, Johnson & Johnson Health Care Compliance & Privacy.
Our first article in this issue comes from Anthony Murphy, who has many years’ experience of working internationally, both in private companies and for the UK government, although he has never worked in our industry. ....
CLICK HERE TO DOWNLOAD THE EDITORIAL OF THIS ISSUE
Please download a free sample copy of Life Science Compliance by clicking here
www.lifesciencecompliance.info
...The distinction between the classroom and e-learning is dissolving with most classroom education including online or technology-enabled components...
